Santen Pharmaceutical Co., Ltd.
Text Size
A
A
A
For Patients
For
Patients
EMEA
Asia
Japan
Investors & Media
Investors
& Media
Management Policies
Financial Summary
Latest IR Documents
IR Library
Other IR Information
Stock Information
IR Contact
Partnering
Partnering
Areas of Interest
Our Partners
Contact Us
R&D
CSR
CSR
CSR at Santen
CSR through Business
Activities
Fair Business
Human Rights
Labour, Occupational
Health & Safety
Environment
Good Corporate Citizen
Stakeholder Engagement
Supporting Sports for
the Visually Impaired
CSR Library
About Us
About Us
Greetings
Santen's Values
Santen's Vision
Efforts to Enhance Patients'
Satisfaction
Business Activities
Quality Compliance
Corporate Governance
Overview
Home
Santen Global
Contact
Careers
Santen Global
Japan
Headquarters (Santen Pharmaceutical Co., Ltd.) (Japanese)
Headquarters (Santen Pharmaceutical Co., Ltd.) (English)
Asia
China (Santen Pharmaceutical (China) Co., Ltd.)
Korea (Santen Pharmaceutical Korea, Co., Ltd.)
United States
United States (Santen Inc.)
United States (Advanced Vision Science, Inc.)
United States (InnFocus Inc.)
EMEA (Europe, the Middle
East and Africa)
Belgium, the Netherlands & Luxembourg
Bulgaria
Czech Republic
Denmark
Finland (Santen Oy)
France (Santen S.A.S.)
Germany (Santen GmbH)
Hungary
Italy (Santen Italy s.r.l.)
Norway
Poland
Portugal
Romania
Russia
Spain (Santen Pharmaceutical Spain, S.L.)
Sweden (SantenPharma AB)
Switzerland & Austria (Santen SA)
UK & Ireland (Santen Ltd.)
Home
News
2019
2019 News
Show All
News Release
Information
Show All
News Release
Information
01.08.2019
News Release
Santen Updates Pipeline in Corporate Presentation of January 8, 2019
